OPN is increased in airway secretions during chronic airway inflammation and is detectable at high concentrations in sputum and bronchoalveolar fluid in diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD)11–14. This evidence concerns the gene SPP1 and asthma.